TrademarkDir
PATHOLYTIX PRECLINICAL
LIVE

Serial Number

79369606

Owner

Deciphex Limited

Attorney

Vincent J. Badolato

Filing Date

Dec 13, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PATHOLYTIX PRECLINICAL Trademark

Serial Number: 79369606 • Registration: 7673977

PATHOLYTIX PRECLINICAL is a trademark filed by Deciphex Limited on December 13, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Deciphex Limited (4 trademarks)

Invent, DCU

Entity Type: 99

Trademark Details

Filing Date

December 13, 2022

Registration Date

February 4, 2025

Published for Opposition

December 17, 2024

Goods & Services

Pathology services, namely, medical pathology services that manage, view, and analyze pre-clinical pathology images assisting with the drug treatment planning purposes

Scientific and laboratory devices for treatment using electricity not for medical purposes, namely, laboratory devices that manage, view, and analyze non-clinical pathology images

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 12, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 21, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 20, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 4, 2025 FICR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 1, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 1, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 1, 2025 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 4, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 4, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 25, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 22, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 22, 2024 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 2, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 16, 2024 OPNS
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 13, 2024 GNFN
FINAL REFUSAL E-MAILED
Aug 13, 2024 GNFR
FINAL REFUSAL WRITTEN
Aug 13, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2024 CRFA
ASSIGNED TO LIE
Jun 14, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 16, 2024 TROA
NOTICE OF REVIVAL - E-MAILED
Apr 16, 2024 NREV
PETITION TO REVIVE-GRANTED
Apr 16, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Apr 16, 2024 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 15, 2024 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 15, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 15, 2024 ABN2
REFUSAL PROCESSED BY IB
Oct 25, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 2, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 2, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 20, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 19, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 18, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 23, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 19, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 18, 2023 REPR

Related Trademarks

More from this Owner

D DECIPHEX logo

D DECIPHEX

D DECIPHEX logo

D DECIPHEX

D DECIPHEX logo

D DECIPHEX

DIAGNEXIA logo

DIAGNEXIA

DIAGNEXIA logo

DIAGNEXIA

DIAGNEXIA logo

DIAGNEXIA